Treatment patterns and survival outcomes in patients with non-metastatic early-onset pancreatic cancer

Figure 3 Treatment outcomes in localized and locally advanced disease. A: Overall survival (OS) with surgery alone and adjuvant therapy (AT)/neoadjuvant therapy (NAT) in patients with localized disease; B: Disease-free survival with surgery alone and AT/NAT in patients with localized disease; C: OS with chemotherapy, radiotherapy-based combination therapy (RCT), and surgery in patients with locally advanced disease; D: Progression-free survival with chemotherapy, RCT, and surgery in patients with locally advanced disease. RCT: Radiotherapy-based combination therapy.